333

NGENEBIO

No trades
See on Supercharts
Market capitalization
‪54.13 B‬KRW
−1010KRW
‪−12.77 B‬KRW
‪4.35 B‬KRW
‪8.21 M‬
Beta (1Y)
1.51

About NGENEBIO

CEO
Dae-Chul Choi
Headquarters
Seoul
Employees (FY)
110
Founded
2015
ISIN
KR7354200008
FIGI
BBG00Y1QKB54
NGeneBio Co., Ltd. engages in the research and development of diagnostic products related to cancer. Its products include next generation sequencing based testing kit for in vitro diagnosis (IVD), anti-cancer companion diagnostics, prenatal diagnosis kit (IVD) for rare diseases and analysis software. The company was founded on October 30, 2015 and is headquartered in Seoul, South Korea.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 354200 is 4275 KRW — it has increased by 1.79% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange NGENEBIO stocks are traded under the ticker 354200.
354200 stock is 8.31% volatile and has beta coefficient of 1.51. Check out the list of the most volatile stocks — is NGENEBIO there?
Yes, you can track NGENEBIO financials in yearly and quarterly reports right on TradingView.
354200 stock has fallen by 40.21% compared to the previous week, the month change is a 17.95% fall, over the last year NGENEBIO has showed a 41.52% decrease.
354200 net income for the last quarter is ‪−836.03 M‬ KRW, while the quarter before that showed ‪−6.90 B‬ KRW of net income which accounts for 87.89% change. Track more NGENEBIO financial stats to get the full picture.
Today NGENEBIO has the market capitalization of ‪55.10 B‬, it has decreased by 5.77% over the last week.
No, 354200 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 354200 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NGENEBIO stock right from TradingView charts — choose your broker and connect to your account.
354200 reached its all-time high on Dec 15, 2020 with the price of 40900 KRW, and its all-time low was 3995 KRW and was reached on Mar 8, 2024.
See other stocks reaching their highest and lowest prices.
As of Apr 27, 2024, the company has 110.00 employees. See our rating of the largest employees — is NGENEBIO on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NGENEBIO technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NGENEBIO stock shows the sell signal. See more of NGENEBIO technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NGENEBIO EBITDA is ‪−12.08 B‬ KRW, and current EBITDA margin is −277.67%. See more stats in NGENEBIO financial statements.